IMMUNEED Trademark

Trademark Overview


On Wednesday, July 13, 2022, a trademark application was filed for IMMUNEED with the United States Patent and Trademark Office. The USPTO has given the IMMUNEED trademark a serial number of 97501249. The federal status of this trademark filing is REGISTERED as of Tuesday, February 27, 2024. This trademark is owned by Immuneed AB. The IMMUNEED trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Testing, biochemical analysis, characterization in the nature of testing to determine pharmaceutical benefits, research and development of pharmaceutical products and vaccine products for others; pharmaceutical research and development; medical and pharmacological research services; testing and analysis of immunotherapy services to assure compliance with industry standards; research and development of immunotherapy treatment methods; biochemical research; immunotherapeutic research; scientific genetics research; immunotherapeutic research in the field of drug safety and immunology; pharmaceutical drug development services; research relating to medicines; drug discovery services; laboratory research in the field of medicine, immunotherapy and cancer
immuneed

General Information


Serial Number97501249
Word MarkIMMUNEED
Filing DateWednesday, July 13, 2022
Status700 - REGISTERED
Status DateTuesday, February 27, 2024
Registration Number7313402
Registration DateTuesday, February 27, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 12, 2023

Trademark Statements


Pseudo MarkIMMUNE
Goods and ServicesTesting, biochemical analysis, characterization in the nature of testing to determine pharmaceutical benefits, research and development of pharmaceutical products and vaccine products for others; pharmaceutical research and development; medical and pharmacological research services; testing and analysis of immunotherapy services to assure compliance with industry standards; research and development of immunotherapy treatment methods; biochemical research; immunotherapeutic research; scientific genetics research; immunotherapeutic research in the field of drug safety and immunology; pharmaceutical drug development services; research relating to medicines; drug discovery services; laboratory research in the field of medicine, immunotherapy and cancer

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 2, 2022
Primary Code042
First Use Anywhere DateThursday, June 9, 2022
First Use In Commerce DateThursday, June 9, 2022

Trademark Owner History


Party NameImmuneed AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressUppsala S-75341
SE

Party NameImmuneed AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressUppsala S-75341
SE

Party NameImmuneed AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressUppsala S-75341
SE

Trademark Events


Event DateEvent Description
Tuesday, February 27, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 27, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, December 12, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 12, 2023PUBLISHED FOR OPPOSITION
Wednesday, November 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 9, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 26, 2023ASSIGNED TO LIE
Friday, May 26, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, May 18, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, May 18, 2023FINAL REFUSAL E-MAILED
Thursday, May 18, 2023FINAL REFUSAL WRITTEN
Tuesday, May 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 2, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 2, 2023NON-FINAL ACTION E-MAILED
Tuesday, May 2, 2023NON-FINAL ACTION WRITTEN
Thursday, April 27, 2023ASSIGNED TO EXAMINER
Tuesday, August 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 16, 2022NEW APPLICATION ENTERED